GNMSFGenmab A/S
Price Chart
Loading chart...
About Genmab A/S (GNMSF)
Genmab A/S (GNMSF) is a Biotechnology company headquartered in Plainsboro, NJ, United States whose shares trade over-the-counter on the Pink tier.
Genmab is an international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer.
GNMSF key facts
- Ticker symbol
- GNMSF
- Market tier
- Pink
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Plainsboro, NJ, United States
- Country of incorporation
- DK
- Year of incorporation
- 1999
- Employees
- 179
- Estimated market cap
- $12.00B (as of Apr 11, 2025)
- Shares outstanding
- 65,718,456
- Reporting standard
- U.S. Reporting: SEC Reporting
- Audit status
- Audited
- Fiscal year end
- 12/31
Genmab A/S leadership
- Jan G. J. van de Winkel — President, CEO
- David A. Eatwell — CFO
- Rachel Curtis Gravesen — SVP, Inv. Rel.
Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with G
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for Genmab A/S (GNMSF) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Biotechnology Companies on OTC Markets
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Company Leadership
Company Officers
Social Media
Business Details
Stock Details
Loading modules...